Long Term Safety and Efficacy of Biphasic Insulin Aspart 30 in Type 2 Diabetes

Exclusion Criteria

• •Persistent non-compliance with study medication, visit schedules or other trial specific procedures during the preceding trial
• •Fulfilment of any withdrawal criteria prior to and including the final visit of the BIAsp-1234.
• •Females only: breast feeding, intention of becoming pregnant, or judged to be using inadequate contraceptive measures (adequate contraceptive methods are sterilisation,IUD (Intra Uterine Device), oral contraceptives or barrier methods)
• •Known or suspected allergy to trial product or related products
• •Development since entry into the previous trial of late diabetic micro or macro vascular complications, which in the opinion of the Investigator indicates a progressed state of disease